The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 11, 2017

Filed:

Jan. 12, 2011
Applicants:

Fulvio Foschini, Rome, IT;

Pierre Roy, Paris, FR;

Edoardo Stagni, Catania, IT;

Giovanni Cavallo, Rome, IT;

Giulio Luciani, Bagno a Ripoli, IT;

Inventors:

Fulvio Foschini, Rome, IT;

Pierre Roy, Paris, FR;

Edoardo Stagni, Catania, IT;

Giovanni Cavallo, Rome, IT;

Giulio Luciani, Bagno a Ripoli, IT;

Assignee:

SOOFT ITALIA SPA, Montegiorgio, IT;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 9/00 (2006.01); A61K 31/525 (2006.01); A61N 1/04 (2006.01); A61N 1/32 (2006.01); A61N 1/30 (2006.01); A61N 5/06 (2006.01);
U.S. Cl.
CPC ...
A61F 9/0026 (2013.01); A61K 31/525 (2013.01); A61N 1/044 (2013.01); A61N 1/0436 (2013.01); A61N 1/0448 (2013.01); A61N 1/30 (2013.01); A61N 1/325 (2013.01); A61N 5/0613 (2013.01); A61F 9/0008 (2013.01);
Abstract

Ocular iontophoresis device and method for delivering any ionized drug solution to the cornea includes: a reservoir containing a solution suitable to be positioned on the eye; an active electrode disposed in or on the reservoir; and a passive electrode suitable to be placed on the skin of the subject, elsewhere on the body; elements for irradiating the cornea surface with suitable light for obtaining corneal cross-linking after the drug delivery; wherein the reservoir and the active electrode are transparent to UV light and/or visible light and/or IR light. The method includes: positioning the iontophoretic device on the eye to be treated; driving the solution by a cathodic current applied for 0.5 to 5 min, at an intensity not higher than 2 mA; and thereafter irradiating, with UV light for 5 to 30 min at a power of 3 to 30 mW/cm; thereby obtaining the corneal cross-linking of the solution.


Find Patent Forward Citations

Loading…